Promacta / Revolade 25 mg Alternative – Elopag (Eltrombopag) 25 mg Tablet | Everest Pharmaceuticals
Elopag 25 mg (Eltrombopag) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Promacta / Revolade (Novartis). It belongs to the thrombopoietin receptor agonist class and is used in selected immune thrombocytopenia and aplastic anemia settings.
Active ingredient: Eltrombopag
Strength: 25 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Doptelet 20 mg Alternative – Avapag (Avatrombopag) 20 mg Tablet | Everest Pharmaceuticals
Avapag 20 mg (Avatrombopag) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Doptelet (Sobi / Dova). It belongs to the thrombopoietin receptor agonist class and is used in selected thrombocytopenia associated with chronic liver disease procedures or immune thrombocytopenia.
Active ingredient: Avatrombopag
Strength: 20 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Balversa 4 mg Alternative – Erdarixen (Erdafitinib) 4 mg Tablet | Everest Pharmaceuticals
Erdarixen 4 mg (Erdafitinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Balversa (Janssen). It belongs to the FGFR inhibitor class and is used in selected FGFR-altered urothelial cancer.
Active ingredient: Erdafitinib
Strength: 4 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Nexavar 200 mg Alternative – Hepanib (Sorafenib) 200 mg Tablet | Everest Pharmaceuticals
Hepanib 200 mg (Sorafenib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Nexavar (Bayer). It belongs to the multikinase inhibitor class and is used in selected liver, kidney and thyroid cancers.
Active ingredient: Sorafenib
Strength: 200 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Cometriq 20 mg Alternative – Caboxen (Cabozantinib) 20 mg Capsule | Everest Pharmaceuticals
Caboxen 20 mg (Cabozantinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Cometriq (Exelixis). It belongs to the multikinase inhibitor class and is used in selected medullary thyroid cancer settings for capsule formulations; other cabozantinib formulations have different approved uses.
Active ingredient: Cabozantinib
Strength: 20 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Lenvima 4 mg Alternative – Lenvaxen (Lenvatinib) 4 mg Capsule | Everest Pharmaceuticals
Lenvaxen 4 mg (Lenvatinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Lenvima (Eisai). It belongs to the multikinase inhibitor class and is used in selected thyroid, renal, liver and endometrial cancer regimens.
Active ingredient: Lenvatinib
Strength: 4 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Votrient 200 mg Alternative – Pazorest (Pazopanib) 200 mg Tablet | Everest Pharmaceuticals
Pazorest 200 mg (Pazopanib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Votrient (Novartis). It belongs to the multitarget kinase inhibitor class and is used in selected advanced renal cell carcinoma and soft tissue sarcoma.
Active ingredient: Pazopanib
Strength: 200 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Zejula 100 mg Alternative – Niranib (Niraparib) 100 mg Capsule | Everest Pharmaceuticals
Niranib 100 mg (Niraparib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Zejula (GSK). It belongs to the PARP inhibitor class and is used in selected ovarian cancer maintenance treatment settings.
Active ingredient: Niraparib
Strength: 100 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Lynparza 150 mg Alternative – Olanib (Olaparib) 150 mg Tablet | Everest Pharmaceuticals
Olanib 150 mg (Olaparib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Lynparza (AstraZeneca / MSD). It belongs to the PARP inhibitor class and is used in selected ovarian, breast, pancreatic and prostate cancers.
Active ingredient: Olaparib
Strength: 150 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Casodex 50 mg Alternative – Calupros (Bicalutamide) 50 mg Tablet | Everest Pharmaceuticals
Calupros 50 mg (Bicalutamide) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Casodex (AstraZeneca). It belongs to the nonsteroidal antiandrogen class and is used in selected prostate cancer hormonal treatment regimens.
Active ingredient: Bicalutamide
Strength: 50 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Erleada 60 mg Alternative – Prostaxen (Apalutamide) 60 mg Tablet | Everest Pharmaceuticals
Prostaxen 60 mg (Apalutamide) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Erleada (Janssen). It belongs to the androgen receptor inhibitor class and is used in selected castration-resistant or castration-sensitive prostate cancer settings.
Active ingredient: Apalutamide
Strength: 60 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.
Zytiga 250 mg Alternative – Abiraxen (Abiraterone acetate) 250 mg Tablet | Everest Pharmaceuticals
Abiraxen 250 mg (Abiraterone acetate) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Zytiga (Janssen). It belongs to the androgen biosynthesis inhibitor class and is used in selected advanced prostate cancer regimens with corticosteroid therapy.
Active ingredient: Abiraterone acetate
Strength: 250 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh
Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.